183 related articles for article (PubMed ID: 31650022)
1. The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor.
Wang Q; Zhao L; Han L; Tuo X; Ma S; Wang Y; Feng X; Liang D; Sun C; Wang Q; Song Q; Li Q
Mol Ther Oncolytics; 2019 Dec; 15():21-29. PubMed ID: 31650022
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
3. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
4. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
[TBL] [Abstract][Full Text] [Related]
5. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study.
Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E
Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients.
Liu Y; Meucci S; Sheng L; Keilholz U
Oncotarget; 2017 Sep; 8(44):77928-77941. PubMed ID: 29100436
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.
Markou AN; Londra D; Stergiopoulou D; Vamvakaris I; Potaris K; Pateras IS; Kotsakis A; Georgoulias V; Lianidou E
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980762
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer.
Kondo Y; Hayashi K; Kawakami K; Miwa Y; Hayashi H; Yamamoto M
BMC Cancer; 2017 May; 17(1):311. PubMed ID: 28468669
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
[TBL] [Abstract][Full Text] [Related]
12. Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer.
De Gregorio A; Friedl TWP; Huober J; Scholz C; De Gregorio N; Rack B; Trapp E; Alunni-Fabbroni M; Riethdorf S; Mueller V; Schneeweiss A; Pantel K; Meier-Stiegen F; Jaeger B; Hartkopf A; Taran FA; Fasching PA; Janni W; Fehm T
JCO Precis Oncol; 2017 Nov; 1():1-12. PubMed ID: 35172510
[TBL] [Abstract][Full Text] [Related]
13. Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.
Shaw JA; Guttery DS; Hills A; Fernandez-Garcia D; Page K; Rosales BM; Goddard KS; Hastings RK; Luo J; Ogle O; Woodley L; Ali S; Stebbing J; Coombes RC
Clin Cancer Res; 2017 Jan; 23(1):88-96. PubMed ID: 27334837
[TBL] [Abstract][Full Text] [Related]
14. Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.
Bingham C; Fernandez SV; Fittipaldi P; Dempsey PW; Ruth KJ; Cristofanilli M; Katherine Alpaugh R
Breast Cancer Res Treat; 2017 Jun; 163(2):219-230. PubMed ID: 28271309
[TBL] [Abstract][Full Text] [Related]
15. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
Fernandez SV; Bingham C; Fittipaldi P; Austin L; Palazzo J; Palmer G; Alpaugh K; Cristofanilli M
Breast Cancer Res; 2014 Oct; 16(5):445. PubMed ID: 25307991
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
[TBL] [Abstract][Full Text] [Related]
18. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
[TBL] [Abstract][Full Text] [Related]
19. Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities.
Liebs S; Eder T; Klauschen F; Schütte M; Yaspo ML; Keilholz U; Tinhofer I; Kidess-Sigal E; Braunholz D
Oncogene; 2021 Aug; 40(33):5204-5212. PubMed ID: 34230613
[TBL] [Abstract][Full Text] [Related]
20. Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.
Buim ME; Fanelli MF; Souza VS; Romero J; Abdallah EA; Mello CA; Alves V; Ocea LM; Mingues NB; Barbosa PN; Tyng CJ; Chojniak R; Chinen LT
Cancer Biol Ther; 2015; 16(9):1289-95. PubMed ID: 26252055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]